Stay updated on Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Sign up to get notified when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.

Latest updates to the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page
- Check5 days agoChange DetectedPage revision updated from v3.4.2 to v3.4.3. The visible study details and layout remain unchanged.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedAdded site revision label 'Revision: v3.4.2'; removed the prior operational notice and revision 'Revision: v3.4.1' related to government funding and operating status.SummaryDifference0.2%

- Check41 days agoChange DetectedNotice about government funding lapse is added at the top of the page, and a new PubMed publication citation related to the study is included. Page revision identifiers updated from v3.4.0 to v3.4.1; to avoid alerts for small changes, set an alert condition.SummaryDifference0.2%

- Check48 days agoChange DetectedAdministrative updates to the page, including Show glossary, Last Update Submitted that Met QC Criteria, Last Update Posted, No FEAR Act Data, and Revision: v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page shows metadata updates (e.g., 2025-12-22 and 2026-01-14) without changes to the study design, eligibility criteria, interventions, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page revision history now shows a new entry for v3.3.4, replacing the previous v3.3.3 entry.SummaryDifference0.0%

Stay in the know with updates to Durvalumab Combo in Advanced Liver Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Durvalumab Combo in Advanced Liver Cancer Clinical Trial page.